Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
108041 jiv389.pdf (273.4Kb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
Sando, Mary Mwanyika
MetadataShow full item record
CitationLi, Nan, Mary Mwanyika Sando, Donna Spiegelman, Ellen Hertzmark, Enju Liu, David Sando, Lameck Machumi, Guerino Chalamilla, and Wafaie Fawzi. 2015. “Antiretroviral Therapy in Relation to Birth Outcomes among HIV-Infected Women: A Cohort Study.” Journal of Infectious Diseases 213 (7): 1057–64. https://doi.org/10.1093/infdis/jiv389.
AbstractAlthough the beneficial effects of antiretroviral (ARV) therapy for preventing mother-to-child transmission are indisputable, studies in developed and developing countries have reported conflicting findings on the association between ARV exposure and adverse birth outcomes. We conducted a prospective observational study at 10 human immunodeficiency virus (HIV) care and treatment centers in Dar es Salaam, Tanzania. Multivariate log-binomial regression was used to investigate the associations between ARV use and adverse birth outcomes among HIV-negative HIV-exposed infants. Our findings demonstrate an increased risk of adverse birth outcomes associated with the use of highly active antiretroviral therapy during pregnancy. Further studies are needed to investigate the underlying mechanisms and identify the safest ARV regimens for use during pregnancy.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41384647
- SPH Scholarly Articles